Previous close | 6.53 |
Open | 6.44 |
Bid | 6.25 x 100 |
Ask | 6.54 x 100 |
Day's range | 6.18 - 6.71 |
52-week range | 5.85 - 18.65 |
Volume | |
Avg. volume | 94,906 |
Market cap | 116.378M |
Beta (5Y monthly) | 0.48 |
PE ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
The average of price targets set by Wall Street analysts indicates a potential upside of 229.3% in Nuvectis Pharma (NVCT). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.
Performance Analysis and Future Outlook Amidst Clinical Progress
Just because a business does not make any money, does not mean that the stock will go down. For example, although...